Gut Microbiome Changes Linked to Precancerous Colon Polyps
Understanding the link between the gut microbiome and polyp growth opens the door to potential screenings and treatments.
Press Release5 Minute ReadSep | 2 | 2021
Immune cells in some human colorectal tumors congregate in clusters, scientists report in Cell. The researchers, from MGH, the Broad Institute of MIT and Harvard, MIT, the Evergrande Center for Immunologic Diseases at Brigham and Women’s Hospital and Harvard Medical School, and Dana-Farber Cancer Institute say that these “hubs” might be likelier to respond to immunotherapies.
Nir Hacohen, PhD, who is the David P. Ryan, MD, Endowed Chair in Cancer Research at MGH and director of the Center for Cancer Immunology, is co-senior author of the study.
Read the full story from the Broad Institute here.
Understanding the link between the gut microbiome and polyp growth opens the door to potential screenings and treatments.
Brief physician training plus reminders can promote discussions about individualized care.
A new study reports a 50 to 60 percent lower risk of colorectal cancer (CRC) among women who started endoscopy screening at age 45 compared to those who had not undergone screening at all.
Using reverse transcriptase inhibitors raises the possibility of a new therapeutic strategy in cancer.
New research finds that non-dividing colon cancer cells use altered glucose metabolism to ward off accumulation of toxic reactive oxidative species.
Colonoscopy or sigmoidoscopy after age 75 reduced colorectal cancer incidence and death related to colorectal cancer in all but those with cardiovascular disease or multiple health conditions.